A common rheumatoid arthritis treatment may offer an effective new therapy for lowering the blood glucose levels of patients with type 2 diabetes, a study has found.
The anti-inflammatory drug Leflunomide lowered blood glucose levels and reversed insulin resistance in mouse models of type 2 diabetes, which suggests that this therapy could be re-purposed as an effective antidiabetic treatment, researchers said.
They said it would be particularly suitable for patients with both diabetes and rheumatoid arthritis.
Rheumatoid arthritis is a chronic condition that causes pain, swelling and stiffness in the joints and affects around 1% of the worldwide population.
Leflunomide has long been approved to treat the condition and previous clinical studies have noted that patients taking the drug tended to have lower blood glucose levels and that obese patients lost weight.
Type 2 diabetes is a lifelong condition that causes a person’s blood sugar level to become too high and is linked to a poor diet, obesity and an inactive lifestyle. There are almost 3.7 million people diagnosed with diabetes in the UK.
In addition to controlling lifestyle factors, many patients require drug therapy to correct their blood glucose levels.
Researchers at Yangzhou University in China said that although previous findings have indicated that Leflunomide may help treat type 2 diabetes, the mechanisms behind these observations had never been fully investigated, nor its effectiveness tested.
Their study, which is published in the Journal of Endocrinology, investigated its effects on the blood sugar levels of two different type 2 diabetes mouse models.
In both models Leflunomide not only normalised blood glucose levels, but also caused cells to start responding to insulin again.
Professor Xiulong Xu, who led the study, said: “We studied how Leflunomide works at a molecular level, and found that it targets a protein involved in desensitising the insulin receptor, which is responsible for instructing the cells to start absorbing sugar from the bloodstream.”
However the drug also acted on other molecular targets in the body, suggesting that more studies are needed to confirm that the antidiabetic effects observed are solely caused by Leflunomide’s effect on the insulin receptor.
“We know some inflammatory factors can also desensitise the insulin receptor, and Leflunomide is an anti-inflammatory, so it may be that it controls blood sugar partly by its anti-inflammatory effect,” Professor Xu added.
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules here